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A 19-year-oldmanwho presentedwith hidradenitis suppurativa
(HS) for 1 year in 2011 was healthy except for a history of being a
hepatitis B carrier. Recurrent pain and discharge affected the
patient’s daily life. Physical examination revealed a tender, bean-
sized, erythematous deep-seated nodule with suppuration
(Figure 1A, arrow), and another sinus tract (Figure 1A, arrowhead)
with an intermittent release of serous, purulent, or blood-stained
discharge, and frequent foul odors over the left axilla. The patient’s
Fitzpatrick skin typewas IV and the disease severity was Stage II ac-
cording to the Hurley scaling system. The lesions improved slightly
and recurred frequently under tetracycline 1 g/day, intralesional
steroids (triamcinolone 5 mg), and incision and drainage therapies
for more than 2 months.
Three sessions of a long-pulsed Alexandrite laser (GentleLase
Laser; Candela Corp. Canton, MA) with parameters of 22–24 J/
cm2-18 mm (ﬂuence-spot size) were applied to the left axilla.
Two to three stacking passes were administered directly on each
of the HS lesions. We chose the energy based on the energy for
epilation and the Fitzpatrick skin type. The immediate endpoint
was erythema around the lesions. A dynamic cooling device was
set at 30/20/0. The interval between each session was 4 weeks.
This procedure was performed under topical anesthesia with favor-
able tolerance. After 2 weeks of the ﬁrst session, a dramatic
improvement in pain and dischargewas noted, inwhich the nodule
and sinus tract subsided. However, a slight recurrence of the HS le-
sions was noted at 1 month after laser treatment, and a biopsy
specimen was obtained from one of the recurrent lesions
(Figure 1B, arrowhead). Histologic examination revealed a mixed
inﬁltration of multinucleated giant cells, lymphocytes, histiocytes,
and plasma cells. Free hair remnants within the mid-dermis were
surrounded by lymphocytes (Figure 2).
Another two sessions of the long-pulsed Alexandrite laser were
implemented, and continued improvement was observed with
each subsequent laser session (Figure 1C). During the laser treat-
ment, the patient was on an intermittent regimen of oral tetracy-
cline for his facial acne. After 8-month follow-up, there was no
recurrence of HS on the left axilla. However, HS occurred over the
right axilla (Figure 1D) after laser treatment on the left axilla. The
HS lesions on the right axilla were still severe under oral antibiotics
(Figure 1E and F), whereas HS lesions on the left axilla (laser-
treated side) improved without recurrence (Figure 1C).
HS, a chronic, relapsing, painful inﬂammation and suppuration
skin disease, causes signiﬁcant morbidity and life impairment. Ac-
cording to the consensus of the HS Foundation in 2009, the diag-
nosis of HS is made by typical appearance, topography, chronicity,
and recurrence. The Hurley scaling system divides HS into three1027-8117/$ – see front matter Copyright  2013, Taiwanese Dermatological Associatio
http://dx.doi.org/10.1016/j.dsi.2013.04.007stages according to its severity, presence of abscess, tract formation,
and cicatrization.1
The pathogenesis of HS is initiated by follicular occlusion, fol-
lowed by perifollicular inﬂammation, follicular infundibulum
rupture, and abscess formation, resulting in sinus tract formation
and scarring. The apocrine glands, previously thought to be the
inciting factor, seem to be secondary factors.2
Treatment modalities, including conservative, medical, and sur-
gical strategies, are mostly of limited effectiveness and recurrences
often occur. Our patient received serial treatments consisting of
systemic antibiotics, anti-inﬂammatory agents, and incision with
drainage. Despite these treatments, recurrent pain and purulent
discharge persisted.
Unlike other immunosuppressive and biologic agents, the laser
device provides the advantages of local treatment without systemic
side effects. Carbon dioxide laser excisionwith secondary healing is
used to treat mild tomoderate diseases. Its superiority compared to
classic surgery is still under debate. Long duration of wound heal-
ing, scar formation, and recurrences are the main drawbacks of
carbon dioxide laser excision.1 In a recent study analysis, the
long-pulsed neodymium:yttrium-aluminum-garnet (Nd:YAG)
laser was demonstrated to improve HS at a success rate of 72.7%.3
The absence of open wounds, less scarring, and prevention of
new lesion formation make the long-pulsed Nd:YAG laser a prom-
ising treatment.
Similar responses of the 755-nm Alexandrite laser in our case
included obvious improvement in discharge and pain; no recur-
rence or exacerbation exhibited after a course of laser therapy.
The biopsy results of mixed inﬂammation and remnants of hair fol-
licles at 4 weeks following the ﬁrst laser treatment session were
also similar.3,4 However, a slight recurrence after the ﬁrst session
of long-pulsed Alexandrite laser therapy was not mentioned in
the long-pulsed Nd:YAG laser treatment. Instead, initial worsening
with increasing inﬂammation and drainage was noted during the
ﬁrst week after the long-pulsed Nd:YAG laser treatment.3,4 In our
patient, the HS discharge became dry immediately and nodules
subsided gradually after the laser treatment.
The possible mechanism of laser therapy in HS is deocclusion of
the follicular unit by destruction of the hair shaft and decrease of
inﬂammatory lesions by photothermolysis. Statistical studies on
epilation have shown that the long-pulsed Alexandrite laser pro-
vides more efﬁciency and less injury than the Nd:YAG laser dose
because of less absorptive competitionwith melanin and an appro-
priate wavelength to reach hair shaft depths.5 Theoretically, the
Alexandrite laser should provide better results than the Nd:YAG
laser for treating HS. In contrast to the results of a 22-patient, pro-
spective, randomized controlled trial of HS treatment with then. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Left axilla-laser treatment side. (A) Prior to laser treatment, a nodule (arrow) and another sinus tract (arrowhead) are present. (B) Four weeks after the ﬁrst laser session, mild
recurrence is noted. A biopsywas obtained fromone of the recurrent lesions (arrowhead). (C) At 8-month follow-up after threemonthly laser sessions, only red and brownpigmentation
exhibit no recurrence. Right axilla-antibiotics treatment side. (D)NewonsetHS lesion. (E) Fourweeks sinceonset. (F) Sevenmonthsafteronset, recurrent andextensive lesions are present.
Figure 2 One month after laser treatment. (A) Inﬁltration consists of histiocytes, lymphocytes, plasma cells, and multinucleated giant cells (hematoxylin-eosin stain; original
magniﬁcation: 20); (B) Free hair remnants within dermis are surrounded by lymphocytes (hematoxylin-eosin stain; original magniﬁcation: 200).
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our case exhibited obvious improvement of HS after the ﬁrst ses-
sion of the long-pulsed Alexandrite laser (Figure 1B). Our patient
received two additional treatment sessions and exhibited further
improvement without recurrence in the 8-month follow-up
(Figure 1C).
In conclusion, our histopathology results corresponded to the
suggested mechanism of the long-pulsed Nd:YAG laser for treating
HS, including deocclusion of the hair follicle followed by drainage
of the inﬂammatory lesion and destruction of the follicular unit.
The long-pulsed Nd:YAG laser has been shown to be a treatment
advance for this highly disabling condition in both clearing preex-
isting lesions and preventing new eruptions. Based on the concept
of epilation and our case observations, we propose that the long-
pulsed Alexandrite laser may provide at least the same efﬁcacy as
that of the Nd:YAG laser. Large randomized clinical studies are war-
ranted to clarify the role and indication of the Alexandrite laser for
the treatment of HS.
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